Update on the treatment of sexually transmitted infections in pregnancy - 2

International Journal of STD and AIDS

Volumn 10, Issue 10, 1999, Pages 636-642

  Brocklehurst, Peter ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Genital herpes; Hepatitis; Molluscum contagiosum; Pregnancy; Warts

Indexed keywords

ACICLOVIR; INTERFERON; TRICHLOROACETIC ACID;

BREAST MILK; CLINICAL TRIAL; CONDYLOMA; DISEASE TRANSMISSION; FEMALE; FUTUROLOGY; GENITAL HERPES; HEPATITIS B; HEPATITIS C; HUMAN; MOLLUSCUM CONTAGIOSUM; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SCREENING; SEXUALLY TRANSMITTED DISEASE; VACCINATION;

ANTIVIRAL AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 0032819273     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991913187     Document Type: Review

References (63)

1. 1 de Ruiter A, Brocklehurst P. HIV infection in pregnancy. Int J STD AIDS 1988;9:647-55
2. 2 Peacock JE, Sarubbi FA. Disseminated herpes simplex virus infection during pregnancy. Obstet Gynecol 1983;61: 13-17
3. 3 Whitley RJ, Arvin AM. Herpes simplex virus infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders, 1995
4. 4 Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971;110:825-37
5. 5 Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987;316:240-4
6. 6 Arvin AM, Hensleigh PA, Prober CG, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315:796-800
7. 7 Sullender WM, Yasukawa LL, Schwartz M, et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 at delivery, and infants with neonatal herpes. J Infect Dis 1988;157:164-71
8. 8 Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:432-42
9. 9 Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52
10. 10 Centers for Disease Control. Pregnancy outcomes following systemic prenatal acyclovir exposure. June 1, 1984-June 30, 1993. MMWR 1993;42:806-9
11. 11 Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA 1993;270:77-82
12. 12 Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD Jr. Acyclovir suppression to prevent Cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87: 69-73
13. 13 Brocklehurst P, Carney O, Ross E, Mindel A. The management of recurrent genital herpes infection in pregnancy: a postal survey of obstetric practice. Br J Obstet Gynaecol 1995;102:791-7
14. 14 Gibbs R, Amstey M, Lezotte D. Role of Cesarean delivery in preventing neonatal herpes virus infection. JAMA 1993;270:94-5
15. 15 Libman MD, Dascal A, Kramer MS, Mendelson J. Strategies for prevention of neonatal infection with herpes simplex virus: a decision analysis. Rev Infect Dis 1991;13:1093-104
16. 16 Kaye EM, Dooling EC. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology 1981;31:1045-7
17. 17 Parvey LS, Chi'ien LT. Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrode. Pediatrics 1980;65:1150-3
18. 18 Stray-Pedersen B. Acyclovir in late pregnancy to prevent neonatal herpes simplex (letter). Lancet 1990;336:756
19. 19 Brocklehurst P, Kinghorn G, Carney O, et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 1998;105:275-80
20. 20 Van EJ, Peeters M, Ten HP. Neonatal herpes policy in The Netherlands. Five years after a consensus conference. J Perinal Med 1993;21:371-5
21. 21 Vonau B, Low-Beer N, Barton SE, Smith JR. Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital. Br J Obstet Gynaecol 1997;104:347-9
22. 22 Shen R, Thin RN. Herpes simplex virus infection in pregnancy and its management. Int J STD AIDS 1992;3:316-18
23. 23 Wilson P, Cropper L, Sharp I. Apparent increase in the prevalence of herpes simplex virus type I genital infections among women. Genilourin Med 1994;70:228
24. 24 Barton TG, Kinghorn GR, Najem S, Al-Omar LS, Potter CW. Incidence of herpes simplex virus type 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis 1982;58:44-7
25. 25 Brocklehurst P, Cowan F. Genital herpes simplex virus infection pregnancy: new proposals to improve screening and reduce neonatal risk. J Obstet Gynaecol 1996;16:132
26. 26 Brown ZA, Vontver LA, Benedetti J, et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246-51
27. 27 McIntosh D, Isaacs D. Herpes simplex virus infection in pregnancy. Arch Dis Child 1992;67:1137-8
28. 28 Lissauer T, Jeffries D. Preventing neonatal herpes infection. Br J Obstet Gynaecol 1989;96:1015-18
29. 29 Scott LL, Dobson AT, Hollier LM, Little BB. Prophylactic acyclovir to prevent neonatal herpes - a murine model. Am J Obstet Gynecol 1997;176:S31
30. 30 Arvin AM, Maladonado YA. Other virus infections of the fetus and newborn. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saudners, 1995
31. 31 Centers for Disease Control. 1998. Sexually transmitted disease treatment guidelines. MMWR 1998;47:88-94
32. 32 Syed A, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled double-blind study. Dermatology 1994;189:65-8
33. 33 Garry R, Jones R. Relationship between cervical condylomata, pregnancy and subclinical papillomavirus infection. J Reprod Med 1985;30:393-6
34. 34 Fife KH, Rogers RE, Zwickl BW. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy. J Infect Dis 1987;156:904
35. 35 Hording U, Iversen AK, Sebbelov A, Bock JE, Norrild B. Prevalence of human papillomavirus types 11, 16 and 18 in cervical swabs. A study of 1362 pregnant women. Eur J Obstet Gynaecol Reprod Med 1990;35:191-8
36. 36 Peng TC, Searle CP, Shah KV, Repke JT, Johnson TR. Prevalence of human papillomavirus infections in term pregnancy. Am J Perinatol 1990;7:189-92
37. 37 Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:649-56
38. 38 Puranen M, Yliskoski M, Saarikoski S, Syranen K, Syrjanen S. Vertical transmission of human papillomatosis from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 1996;174:694-9
39. 39 Quick CA, Kryzyck RA, Watts SL, et al. Relationship between condylomata and laryngeal papillomatosis. Ann Otol 1980;89:467-71
40. 40 Pakarian F, Kaye J, Cason J, et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol 1994;101:514-17
41. 41 Shah K, Kashima H, Polk F, Shah F, Abbey H, Abramson A. Rarity of Caesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 1986;68:795-9
42. 42 Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol 1998;91:92-6
43. 43 Newell M-L, Thorne C, Pembrey L, Nicoll A, Goldberg D, Peckham C. Antenatal screening of hepatitis B infection and syphilis in the UK. Br J Obstet Gynaecol 1999;106:66-71
44. 44 Zhu QR, Duan SC, Xu HF, et al. Transplacental transmission of hepatitis B virus from mother to infant. Chin J Infect Dis 1989;7:159
45. 45 Tong NJ, Thursby M, Rakela J, et al. Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology 1981;80:999-1004
46. 46 Larouze B, Saimot G, Lustbader ED, London WT, Werner BG, Payet M. Host response to hepatitis-B infection in patients with primary hepatic carcinoma and families. A case/control study in Senegal, West Africa. Lancet 1976;2:534-8
47. 47 Szmuness W. Hepatocellular carcinoma and hepatitis B virus: evidence for a causal association. Prog Med Virol 1978;24:40-69
48. 48 Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994;44:14-51
49. 49 Boxall EH, Jefferson TO, Domicheli V, Laurichesse H, Pratt M, Deeks J. Vaccines for preventing hepatitis B in high risk newborn infants (Protocol for a Cochrane review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 1999
50. 50 Qirong Z, Xinhuan G, Huafang, Shucheng D. A preliminary study on interruption of HBV transmission in uterus. Chin Med J 1997;110:145-7
51. 51 Universal antenatal screening for hepatitis B and immunisation of babies at risk. CDR Wkly 1998;8:284
52. 52 Zeldis JB, Crumpacker CS. Hepatitis. In: Remington JS, Klein JO, eds. Infecfious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders, 1995
53. 53 Kim MJ, Alexander JM, Sercecley B, Jackson G, Wendel GD. Hepatitis B (HBV) transmission associated with breast-feeding in infants of chronic carriers. Am J Obstet Gynecol 1997;176:S36
54. 54 Rooney GJ, Gilson RJC. Sexual transmission of hepatitis C infection. Sex Transm Infect 1998;74:399-404
55. 55 Kaldor JM, Archer GT, Buring ML, et al. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 1992;157:227-30
56. 56 Atrah HI, Ala FA, Ahmed MM, et al. Unexplained hepatitis C virus antibody seroconversion in established blood donors. Transfusion 1996;36:339-43
57. 57 Giacchino R, Tasso L, Timitilli A, et al. Vertical transmission of hepatitis C virus infection: usefulness of viremia detection in HIV-seronegative hepatitis C virus-positive mothers. J Pediatr 1998;132:167-9
58. 58 Spencer JD, Latt N, Beeby PJ, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepatitis 1997;4:395-409
59. 59 Mazza C, Ravaggi A, Rodella A, et al. Prospective study of mother-to-infant transmission of hepatitis C (HCV) infection. J Med Virol 1998;54:12-19
60. 60 Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50
61. 61 Leikin E, Reinus J. Invasive monitoring and vertical transmission of hepatitis C virus. Am J Obstet Gynecol 1997;176:S37
62. 62 Niederau C, Heintges T, Haussinger D. Treatment of hepatitis C with alpha-interferon: an analysis of the literature. Hepato-gastroenterology 1996;43:1544-56
63. 63 Zein NN. Vertical transmission of hepatitis C: to screen or not to screen. J Pediatr 1997;130:859-61